First Time Loading...

Sierra Oncology Inc
NASDAQ:SRRA

Watchlist Manager
Sierra Oncology Inc Logo
Sierra Oncology Inc
NASDAQ:SRRA
Watchlist
Price: 54.99 USD Market Closed
Updated: Apr 30, 2024

Sierra Oncology Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sierra Oncology Inc
Cash from Operating Activities Peer Comparison

Comparables:
ZYME
RPTX
FUSN
AUPH
EDT

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Sierra Oncology Inc
NASDAQ:SRRA
Cash from Operating Activities
-$87.7m
CAGR 3-Years
-22%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Zymeworks Inc
NYSE:ZYME
Cash from Operating Activities
-$118.3m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Cash from Operating Activities
-$127.2m
CAGR 3-Years
-176%
CAGR 5-Years
-59%
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Cash from Operating Activities
-$81.8m
CAGR 3-Years
-40%
CAGR 5-Years
-53%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash from Operating Activities
-$33.5m
CAGR 3-Years
22%
CAGR 5-Years
8%
CAGR 10-Years
-22%
Spectral Medical Inc
TSX:EDT
Cash from Operating Activities
-CA$10.7m
CAGR 3-Years
-222%
CAGR 5-Years
-35%
CAGR 10-Years
-2%

See Also

What is Sierra Oncology Inc's Cash from Operating Activities?
Cash from Operating Activities
-87.7m USD

Based on the financial report for Mar 31, 2022, Sierra Oncology Inc's Cash from Operating Activities amounts to -87.7m USD.

What is Sierra Oncology Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-15%

Over the last year, the Cash from Operating Activities growth was -58%. The average annual Cash from Operating Activities growth rates for Sierra Oncology Inc have been -22% over the past three years , -15% over the past five years .